BridgeBio Pharma BBIO
NASDAQ BBIO
$66.91 +1.11 (+1.69%)
At close: Oct 1, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Accumulated Expenses (2018 - 2020)

Updated

BridgeBio Pharma (BBIO) posted Accumulated Expenses of $8.69 million for Q3 2020, up 81.5% from $4.79 million a year earlier but down 24.2% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Accumulated Expenses (2018 - 2020) Analysis & Trends

At the end of FY2019, BridgeBio Pharma's Accumulated Expenses came in at $3.02 million, up 43.8% from FY2018.

  • In prior years, BridgeBio Pharma's Accumulated Expenses was $2.1 million in FY2018.
  • Quarterly Accumulated Expenses has run from a low of $2.1 million in Q4 2018 to a high of $11.46 million in Q2 2020 over five years.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $11.46 million (Q2 2020), $7.47 million (Q1 2020) and $3.02 million (Q4 2019).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 BridgeBio Pharma 12.85 Bn 9.97 Bn 228.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 8.69 Mn
Jun 30, 2020 11.46 Mn
Mar 31, 2020 7.47 Mn
Dec 31, 2019 3.02 Mn
Sep 30, 2019 4.79 Mn
Jun 30, 2019 4.19 Mn
Dec 31, 2018 2.10 Mn
API Access

BridgeBio Pharma Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=BBIO&period=max&api_key=YOUR_API_KEY